Serina Therapeutics (SER) Common Equity (2017 - 2026)
Serina Therapeutics (SER) posted Common Equity of -$37000.0 for Q4 2025, down 102.32% sequentially from $1.6 million in Q3 2025, and down 105.77% YoY from $641000.0 in Q4 2024.
Serina Therapeutics (SER) Common Equity (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Common Equity for 9 years, with the latest figure at -$37000.0 in Q4 2025.
- Quarterly Common Equity fell 105.77% year-over-year to -$37000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$37000.0 (down 105.77% YoY) and the FY2025 annual result came in at -$37000.0, down 105.77% from the prior year.
- Common Equity fell to -$37000.0 in Q4 2025 per SER's latest filing, from $1.6 million in the prior quarter.
- Over five years, Common Equity peaked at $1.6 million in Q2 2025 and troughed at -$37.8 million in Q4 2022.
- A 5-year average of -$15.2 million and a median of -$12.6 million in 2021 frame the typical range for Common Equity.
- The sharpest annual moves came in 2021 and 2025: Common Equity sank 1527.47% in 2021, then jumped 111.53% in 2025.
- Over 5 years, Common Equity stood at -$11.9 million in 2021, then tumbled by 218.13% to -$37.8 million in 2022, then grew by 14.52% to -$32.3 million in 2023, then jumped by 101.98% to $641000.0 in 2024, then tumbled by 105.77% to -$37000.0 in 2025.
- According to Business Quant data, Common Equity over the past three periods registered -$37000.0, $1.6 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.79 Bn |
| 10 | Serina Therapeutics | 45.71 Mn | 22.69 Mn | - | 18.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.73 Mn |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 641,000.00 |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -16.39 Mn |
| Mar 31, 2024 | -28.39 Mn |
| Dec 31, 2023 | -32.29 Mn |
| Sep 30, 2023 | -33.35 Mn |
| Jun 30, 2023 | -35.29 Mn |
| Mar 31, 2023 | -36.12 Mn |
| Dec 31, 2022 | -37.78 Mn |
| Sep 30, 2022 | -15.15 Mn |
| Jun 30, 2022 | -13.26 Mn |
| Mar 31, 2022 | -11.59 Mn |
| Dec 31, 2021 | -11.88 Mn |
| Sep 30, 2021 | -9.98 Mn |
| Jun 30, 2021 | -8.29 Mn |